Cargando…

Relevance of RSV in hospitalized adults and the need for continued testing

Background: RSV is underrecognized in hospitalized adults. A better understanding of RSV in this population could help prioritize targeted viral-testing resources. Hospitalization and in-hospital outcomes are widely accepted as markers of clinical severity with respect to acute respiratory illness (...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Katherine, Monto, Arnold, Talbot, H. Keipp, Gaglani, Manjusha, McNeal, Tresa, Silveira, Fernanda, Zimmerman, Richard, Middleton, Donald, Ghamande, Shekhar, Murthy, Kempapura, Kim, Lindsay, Ferdinands, Jill, Patel, Manish, Martin, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614971/
http://dx.doi.org/10.1017/ash.2022.176
_version_ 1784820314042007552
author Miller, Katherine
Monto, Arnold
Talbot, H. Keipp
Gaglani, Manjusha
McNeal, Tresa
Silveira, Fernanda
Zimmerman, Richard
Middleton, Donald
Ghamande, Shekhar
Murthy, Kempapura
Kim, Lindsay
Ferdinands, Jill
Patel, Manish
Martin, Emily
author_facet Miller, Katherine
Monto, Arnold
Talbot, H. Keipp
Gaglani, Manjusha
McNeal, Tresa
Silveira, Fernanda
Zimmerman, Richard
Middleton, Donald
Ghamande, Shekhar
Murthy, Kempapura
Kim, Lindsay
Ferdinands, Jill
Patel, Manish
Martin, Emily
author_sort Miller, Katherine
collection PubMed
description Background: RSV is underrecognized in hospitalized adults. A better understanding of RSV in this population could help prioritize targeted viral-testing resources. Hospitalization and in-hospital outcomes are widely accepted as markers of clinical severity with respect to acute respiratory illness (ARI). We compared characteristics and clinical outcomes between adults hospitalized with ARI from October 2016 through May 2019. Methods: All hospitalized adults (≥ 18 years) who met a standardized case definition of ARI were prospectively enrolled across 3 respiratory seasons from 9 hospitals participating in the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Demographic data were collected during enrollment interviews, and electronic medical records (EMRs) were reviewed to extract comorbidity data. Throat and nasal swabs collected at enrollment were tested for ARI pathogens using real-time PCR assays at respective HAIVEN research laboratory sites. Characteristics and clinical outcomes of participants were compared using χ(2) or nonparametric tests where appropriate. Multivariable logistic regression models were used to test associations between infection status, characteristics, and clinical outcomes, adjusting for age, sex, race, Charlson comorbidity index (CCI), body mass index (BMI), site, season, and days to admission. Results: In total, 10,311 adults were included, 22.3% (n = 2,300) were aged 18–49 years, 33.2% (n = 3,423) were aged 50–64 years, and 44.5% (n = 4,588) were aged ≥65 years. Moreover, 6% of adults tested positive for RSV (n = 622), 18.8% positive for influenza (n = 1,940), and 75.1% negative for both (n = 7,749). Obesity and age ≥65 years were significantly associated with RSV detection when compared with participants negative for both RSV and influenza. Patients aged 18–49 years and ≥65 years with RSV had significantly higher median CCI scores compared to patients with influenza (Fig. 1.). The proportion of adults with CHF or COPD was significantly (p-value Conclusions: Severe RSV illness may differ from severe influenza illness, and those infected with RSV may have different characteristics than those infected with influenza. Hospitalized adults with RSV infection were more likely to have underlying cardiopulmonary comorbidities and higher CCI scores as well as experience an extended length of hospital stay and need for mechanical ventilation. These data highlight the importance of retaining testing for RSV in older adults hospitalized with ARI. Funding: None Disclosures: None
format Online
Article
Text
id pubmed-9614971
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-96149712022-10-29 Relevance of RSV in hospitalized adults and the need for continued testing Miller, Katherine Monto, Arnold Talbot, H. Keipp Gaglani, Manjusha McNeal, Tresa Silveira, Fernanda Zimmerman, Richard Middleton, Donald Ghamande, Shekhar Murthy, Kempapura Kim, Lindsay Ferdinands, Jill Patel, Manish Martin, Emily Antimicrob Steward Healthc Epidemiol Respiratory Viruses Other than SARS-CoV-2 Background: RSV is underrecognized in hospitalized adults. A better understanding of RSV in this population could help prioritize targeted viral-testing resources. Hospitalization and in-hospital outcomes are widely accepted as markers of clinical severity with respect to acute respiratory illness (ARI). We compared characteristics and clinical outcomes between adults hospitalized with ARI from October 2016 through May 2019. Methods: All hospitalized adults (≥ 18 years) who met a standardized case definition of ARI were prospectively enrolled across 3 respiratory seasons from 9 hospitals participating in the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Demographic data were collected during enrollment interviews, and electronic medical records (EMRs) were reviewed to extract comorbidity data. Throat and nasal swabs collected at enrollment were tested for ARI pathogens using real-time PCR assays at respective HAIVEN research laboratory sites. Characteristics and clinical outcomes of participants were compared using χ(2) or nonparametric tests where appropriate. Multivariable logistic regression models were used to test associations between infection status, characteristics, and clinical outcomes, adjusting for age, sex, race, Charlson comorbidity index (CCI), body mass index (BMI), site, season, and days to admission. Results: In total, 10,311 adults were included, 22.3% (n = 2,300) were aged 18–49 years, 33.2% (n = 3,423) were aged 50–64 years, and 44.5% (n = 4,588) were aged ≥65 years. Moreover, 6% of adults tested positive for RSV (n = 622), 18.8% positive for influenza (n = 1,940), and 75.1% negative for both (n = 7,749). Obesity and age ≥65 years were significantly associated with RSV detection when compared with participants negative for both RSV and influenza. Patients aged 18–49 years and ≥65 years with RSV had significantly higher median CCI scores compared to patients with influenza (Fig. 1.). The proportion of adults with CHF or COPD was significantly (p-value Conclusions: Severe RSV illness may differ from severe influenza illness, and those infected with RSV may have different characteristics than those infected with influenza. Hospitalized adults with RSV infection were more likely to have underlying cardiopulmonary comorbidities and higher CCI scores as well as experience an extended length of hospital stay and need for mechanical ventilation. These data highlight the importance of retaining testing for RSV in older adults hospitalized with ARI. Funding: None Disclosures: None Cambridge University Press 2022-05-16 /pmc/articles/PMC9614971/ http://dx.doi.org/10.1017/ash.2022.176 Text en © The Society for Healthcare Epidemiology of America 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Respiratory Viruses Other than SARS-CoV-2
Miller, Katherine
Monto, Arnold
Talbot, H. Keipp
Gaglani, Manjusha
McNeal, Tresa
Silveira, Fernanda
Zimmerman, Richard
Middleton, Donald
Ghamande, Shekhar
Murthy, Kempapura
Kim, Lindsay
Ferdinands, Jill
Patel, Manish
Martin, Emily
Relevance of RSV in hospitalized adults and the need for continued testing
title Relevance of RSV in hospitalized adults and the need for continued testing
title_full Relevance of RSV in hospitalized adults and the need for continued testing
title_fullStr Relevance of RSV in hospitalized adults and the need for continued testing
title_full_unstemmed Relevance of RSV in hospitalized adults and the need for continued testing
title_short Relevance of RSV in hospitalized adults and the need for continued testing
title_sort relevance of rsv in hospitalized adults and the need for continued testing
topic Respiratory Viruses Other than SARS-CoV-2
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614971/
http://dx.doi.org/10.1017/ash.2022.176
work_keys_str_mv AT millerkatherine relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT montoarnold relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT talbothkeipp relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT gaglanimanjusha relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT mcnealtresa relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT silveirafernanda relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT zimmermanrichard relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT middletondonald relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT ghamandeshekhar relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT murthykempapura relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT kimlindsay relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT ferdinandsjill relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT patelmanish relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting
AT martinemily relevanceofrsvinhospitalizedadultsandtheneedforcontinuedtesting